XML 35 R8.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Material accounting policies | 12 Months Ended
--- | ---
Mar. 31, 2024
Material accounting policies |
Material accounting policies | 3. Material accounting policies Financial instruments Financial assets and financial liabilities, including derivatives, are recognized on the consolidated statements of financial position when the Company becomes a party to the financial instrument or derivative contract. Summary of the Company’s classification and measurements of financial assets and liabilities:
Financial Assets and Liabilities |  | Classification |  | Measurement
Cash and cash equivalents | ​ | Amortized cost | ​ | Amortized cost
Restricted cash | ​ | Amortized cost | ​ | Amortized cost
Accounts payable and accrued liabilities | ​ | Amortized cost | ​ | Amortized cost
Derivative warrant liability | ​ | FVTPL | ​ | Fair value
Convertible notes | ​ | FVTPL | ​ | Fair value
NCAC promissory note | ​ | FVTPL | ​ | Fair value
PGI promissory note | ​ | FVTPL | ​ | Fair value
​ Classification The Company classifies its financial assets and financial liabilities in the following measurement categories: i) those to be measured subsequently at fair value through profit or loss (“FVTPL”); ii) those to be measured subsequently at fair value through other comprehensive income (“FVOCI”); and iii) those to be measured at amortized cost. The classification of financial assets depends on the business model for managing the financial assets and the contractual terms of the cash flows. Financial liabilities are classified as those to be measured at amortized cost unless they are designated as those to be measured subsequently at FVTPL (irrevocable election at the time of recognition). For assets and liabilities measured at fair value, gains and losses are either recorded in net loss or other comprehensive income (loss). The Company reclassifies financial assets only when its business model for managing those assets changes. Financial liabilities are not reclassified. Amortized cost This category includes financial assets that are held within a business model with the objective to hold the financial assets to collect contractual cash flows that meet the sole payments of principal and interest (“SPPI”) criterion. Financial assets classified in this category are measured at amortized cost using the effective interest method. Fair value through profit or loss This category includes derivative instruments as well as quoted equity instruments which the Company has irrevocably elected, at initial recognition or transition, to classify at FVTPL. This category would also include debt instruments of which the cash flow characteristics fail the solely payments of principal and interest (“SPPI”) criterion or are not held within a business model whose objective is either to collect contractual cash flows, or to both collect contractual cash flows and sell. Financial assets in this category are recorded at fair value with changes recognized in net loss. The Company records its financial liabilities including derivatives, convertible loans and promissory notes at FVTPL. Derivatives are mandatorily recorded at FVTPL, whereas the Company has elected to record convertible loans and promissory notes at FVTPL. Financial assets at fair value through other comprehensive income Equity instruments that are not held-for-trading can be irrevocably designated to have their change in fair value recognized through other comprehensive income (loss) instead of through net loss. This election can be made on individual instruments and is not required to be made for the entire class of instruments. Attributable transaction costs are included in the carrying value of the instruments. Financial assets at fair value through other comprehensive income/(loss) are initially measured at fair value and changes therein are recognized in other comprehensive income/(loss). Compound financial instrument and derivative liability The Company determined that the warrants, including public warrants and the private warrants are derivative instruments and should be classified as a financial liability and are measured at FVTPL. Derivative and financial liabilities designated at FVTPL are carried subsequently at fair value with gains or losses recognized in net loss. Each embedded derivative is measured and presented separately unless the whole hybrid financial instrument is designated as at FVTPL. Measurement All financial instruments are required to be measured at fair value on initial recognition, plus, in the case of a financial asset or financial liability not at FVTPL, transaction costs that are directly attributable to the acquisition or issuance of the financial asset or financial liability. Transaction costs of financial assets and financial liabilities carried at FVTPL are expensed in net loss. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest. Financial assets that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortized cost at the end of the subsequent accounting periods. All other financial assets including equity investments are measured at their fair values at the end of subsequent accounting periods, with any changes taken through net loss or other comprehensive income/(loss) (irrevocable election at the time of recognition). For financial liabilities measured subsequently at FVTPL, changes in fair value are recorded in profit and loss, except where changes in fair value are attributable to changes in own credit risk which is recorded in other comprehensive income. Cash and cash equivalents Cash and cash equivalents include cash on hand and, when applicable, short-term, highly liquid deposits which are either cashable or with original maturities of less than three months at the date of their acquisition. Restricted cash Restricted cash comprises a collateral agreement with a major chartered bank in Canada with regards to a credit card facility against which the Company deposited in a guaranteed investment certificate with the bank. Related party transactions Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control. Related parties may be individuals or entities. A transaction is considered to be a related party transaction when there is transfer of resources or obligations between related parties. Change in accounting policy Pursuant to completion of the Business Combination Agreement and NASDAQ listing as explained in Note 1 to the audited consolidated financial statements, on January 25, 2024, the Corporation decided to change the presentation currency of its consolidated financial statements from Canadian Dollars to United States Dollars. The Board of Directors believe that US Dollar financial reporting provides more relevant presentation of the Corporation’s financial position, funding and treasury functions, financial performance and cash flows. A change in presentation currency represents a change in accounting policy in terms of IAS 8 – Accounting Policies, Changes in Accounting Estimates and Errors, requiring the restatement of comparative information. In accordance with IAS 21 – The Effects of Changes in Foreign Exchange Rates, the methodology followed in restating historical financial information from CDN$ to US$. The average and closing rates used in translating the historical financial information from CDN$ to US$ for the various periods were as follows: The closing rate used as at March 31, 2024 was $0.738 and as at March 31, 2023 was $0.7389. The average rate used for the year ended March 31, 2024 was $0.7415, for the year ended March 31, 2023 was $0.7559 and for the year ended March 31, 2022 was $0.8003. The change in presentation currency is a voluntary change which is accounted for retrospectively. For comparative reporting purposes, historical financial information has been translated to United States dollars which is disclosed in the tables below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | ​ |  | March 31,
​ | ​ | 2023 | ​ | Foreign | ​ | 2023
​ | ​ | Reported CAD | ​ | Currency | ​ | Restated USD
Change in presentation currency |  | $ |  | Translation |  | $
ASSETS | ​ |  | ​ |  | ​ |
Current assets | ​ |  | ​ |  | ​ |
Cash and cash equivalents | ​ | 1,805,765 | ​ | (471,485) | ​ | 1,334,280
Restricted cash | ​ | 40,000 | ​ | (10,444) | ​ | 29,556
Other receivables | ​ | 202,150 | ​ | (52,782) | ​ | 149,369
Prepaids | ​ | 104,276 | ​ | (27,226) | ​ | 77,050
Total current assets | ​ | 2,152,192 | ​ | (561,937) | ​ | 1,590,255
TOTAL ASSETS | ​ | 2,152,192 | ​ | (561,937) | ​ | 1,590,255
LIABILITIES | ​ |  | ​ |  | ​ |
Current liabilities | ​ |  | ​ |  | ​ |
Accounts payable and accrued liabilities | ​ | 2,423,467 | ​ | (632,767) | ​ | 1,790,700
TOTAL LIABILITIES | ​ | 2,423,467 | ​ | (632,767) | ​ | 1,790,700
EQUITY | ​ |  | ​ |  | ​ |
Net equity | ​ | (271,275) | ​ | 70,830 | ​ | (200,445)
NET DEFICIT | ​ | (271,275) | ​ | 70,830 | ​ | (200,445)
TOTAL LIABILITIES AND NET DEFICIT | ​ | 2,152,192 | ​ | (561,937) | ​ | 1,590,255
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | ​ |  | March 31,
​ | ​ | 2022 | ​ | Foreign | ​ | 2022 Restated
​ | ​ | Reported CAD | ​ | Currency | ​ | USD
Change in presentation currency |  | $ |  | Translation |  | $
ASSETS | ​ |  | ​ |  |  |
Current assets | ​ |  | ​ |  |  |
Cash and cash equivalents | ​ | 2,191,095 | ​ | (437,658) |  | 1,753,437
Restricted cash | ​ | 40,000 | ​ | (7,990) |  | 32,010
Other receivables | ​ | 49,372 | ​ | (9,862) |  | 39,510
Prepaids | ​ | 6,729 | ​ | (1,344) |  | 5,385
Total current assets | ​ | 2,287,196 | ​ | (456,854) |  | 1,830,342
TOTAL ASSETS | ​ | 2,287,196 | ​ | (456,854) |  | 1,830,342
LIABILITIES | ​ |  | ​ |  |  |
Current liabilities | ​ |  | ​ |  |  |
Accounts payable and accrued liabilities | ​ | 164,500 | ​ | (32,858) |  | 131,642
TOTAL LIABILITIES | ​ | 164,500 | ​ | (32,858) |  | 131,642
EQUITY | ​ |  | ​ |  |  |
Net equity | ​ | 2,122,696 | ​ | (423,996) |  | 1,698,700
NET DEFICIT | ​ | 2,122,696 | ​ | (423,996) |  | 1,698,700
TOTAL LIABILITIES AND NET DEFICIT | ​ | 2,287,196 | ​ | (456,854) |  | 1,830,342
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | ​ |  | March 31,
​ | ​ | 2023 | ​ | Foreign | ​ | 2023
​ | ​ | Reported CAD | ​ | Currency | ​ | Restated USD
Change in presentation currency |  | $ | ​ | Translation | ​ | $
Expenses | ​ |  | ​ |  | ​ |
Sales and marketing | ​ | 9,292 | ​ | (2,263) | ​ | 7,029
Research and development | ​ | 2,126,762 | ​ | (517,867) | ​ | 1,608,895
General and administrative | ​ | 484,382 | ​ | (117,947) | ​ | 366,435
Professional and consulting fees | ​ | 1,655,663 | ​ | (403,153) | ​ | 1,252,510
Loss before other items | ​ | (4,276,099) | ​ | (1,041,230) | ​ | (3,234,869)
Other items | ​ |  | ​ |  | ​ |
Interest income | ​ | 2,054 | ​ | (500) | ​ | 1,554
Foreign exchange gain | ​ | 35,574 | ​ | (8,662) | ​ | 26,912
NET LOSS | ​ | (4,238,471) | ​ | (1,050,392) | ​ | (3,206,403)
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | ​ |  | March 31,
​ | ​ | 2023 | ​ | Foreign | ​ | 2023
​ | ​ | Reported CAD | ​ | Currency | ​ | Restated USD
Change in presentation currency | ​ | $ | ​ | Translation | ​ | $
Net loss | ​ | (4,238,471) | ​ | 1,032,068 | ​ | (3,206,403)
Non-cash adjustment: | ​ |  | ​ |  | ​ |
Share based compensation | ​ | 292,756 | ​ | (71,469) | ​ | 221,287
Foreign exchange | ​ | — | ​ | (84,499) | ​ | (84,499)
​ | ​ | ​ | ​ | ​ | ​ | ​
Changes in working capital: | ​ |  | ​ |  | ​ |
Other receivables | ​ | (152,778) | ​ | 42,920 | ​ | (109,858)
Prepaids | ​ | (97,547) | ​ | 25,882 | ​ | (71,665)
Accounts payable and accrued liabilities | ​ | 2,258,967 | ​ | (599,909) | ​ | 1,659,058
Cash used in operating activities | ​ | (1,937,073) | ​ | 344,993 | ​ | (1,592,080)
​ | ​ | ​ | ​ | ​ | ​ | ​
Proceeds received from Psyence Group Inc | ​ | 1,551,744 | ​ | (378,821) | ​ | 1,172,923
Cash provided from financing activities | ​ | 1,551,744 | ​ | (378,821) | ​ | 1,172,923
​ | ​ | ​ | ​ | ​ | ​ | ​
Change in cash and cash equivalents | ​ | (385,329) | ​ | (33,828) | ​ | (419,157)
Cash and cash equivalents, start of year | ​ | 2,191,095 | ​ | (437,658) | ​ | 1,753,437
Cash and cash equivalents, end of year | ​ | 1,805,765 | ​ | (471,486) | ​ | 1,334,280
​ Research and development Expenditures on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, are recognized in the statements of net loss and comprehensive loss as incurred. Development expenditures are capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to complete development and has sufficient resources to complete development and to use or sell the asset. Other development expenditures are expensed as incurred. Research and development expenses include all direct and indirect operating expenses supporting the products in development. The costs incurred in establishing and maintaining patents are expensed as incurred. Provisions Provisions are recognized when the Company has a present obligation, legal or constructive as a result of a previous event, if it is probable that the Company will be required to settle the obligation and a reliable estimate can be made of the obligation. The amount recognized is the best estimate of the expenditure required to settle the present obligation at the end of the reporting period, taking into account the risks and uncertainties surrounding the obligations. Provisions are reviewed at the end of each reporting period and adjusted to reflect the current best estimate of the expected future cash flows. Foreign currency translation The Financial Statements are presented in USD $ which is PBM’s functional currency. The functional currency of its subsidiary consolidated within these Financial Statements is AUD $. In each individual entity, a foreign currency transaction is initially recorded in the functional currency of the entity, by applying the exchange rate between the functional currency and the foreign currency at the date of the transaction. At the end of the reporting period, monetary assets and liabilities of the Company which are denominated in foreign currencies are translated at the period-end exchange rate. Non-monetary assets and liabilities are translated at rates in effect at the date the assets were acquired, and liabilities incurred. The resulting exchange gains or losses arising on the settlement of monetary items or on translating monetary items at rates different from those at which they were translated on initial recognition, are included in statement of net loss and comprehensive loss in the period in which they arise. For the purpose of presenting these Financial Statements, the assets and liabilities of the subsidiary are translated into USD $ at the exchange rates prevailing at the end of the reporting period. Income and expenses are translated at the average rates for the period. The differences from translating subsidiaries is recorded in reserves. Loss per share The Company presents basic and diluted loss per share data for its common shares. Basic loss per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted loss per share is determined by adjusting the loss attributable to common shareholders and the weighted average number of common shares outstanding, adjusted for the effects of all dilutive potential common shares, which comprise convertible debentures, warrants and share options issued. Share based compensation The fair value of the options and RSUs granted by the Company shall be recognized as an expense in the Consolidated Financial Statements of the Company. The expense shall be recognized over the vesting period of the options. The fair value options shall be determined using the Black-Scholes model. Income taxes Income tax comprises current and deferred tax. Income tax is recognized in profit or loss except to the extent that it relates to items recognized directly in shareholders’ equity, in which case the income tax is also recognized directly in equity or other comprehensive income, in which case the income tax is also recognized directly in equity or other comprehensive income. Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted at the end of the reporting period, and any adjustments to tax payable in respect of previous years. Current tax assets and current tax liabilities are only offset if a legally enforceable right exists to offset the amounts and the Company. Deferred tax is recognized in respect of all qualifying temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the Financial Statements. Deferred income tax is determined on a non-discounted basis using the tax rates and laws that have been enacted or substantively enacted at the end of the reporting period and are expected to apply when the deferred tax asset or liability is settled. Deferred tax assets are offset when there is a legally enforceable right to offset tax assets and liabilities and when the deferred tax balances relate to the same taxation authority. Deferred tax assets are recognized to the extent future recovery is probable. At each reporting period end, deferred tax assets are reduced to the extent that it is no longer probable that sufficient taxable earnings will be available to allow all or part of the asset to be recovered.

X
- Definition The entire disclosure of material accounting policy information applied by the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 117 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pbm_MaterialAccountingPoliciesAbstract
Namespace Prefix: | pbm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration